MPC1 and metabolic dysfunction-associated steatohepatitis: Blocking pyruvate entry into the mitochondria likely helps to ease this flow of carbon, which has been shown with liver Mpc1 deletion in NAFLD [59] and with TZD treatment in NASH [95].